We report on 16 patients with relapsed or refractory B cell acute lymphoblastic leukemia that we treated with autologous T cells expressing the 19-28z chimeric antigen receptor specific to the CD19 antigen.
http://ift.tt/1d8vJTP
http://ift.tt/1d8vJTP
No comments:
Post a Comment